CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alcresta Pharmaceuticals, a specialty pharmaceutical company focused on developing innovative enzyme-based products for gastrointestinal and rare disease, today announced that John Tucker, Chief Executive Officer of Alcresta, will provide a corporate presentation at the 34th Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT (10:30 p.m. ET), on Thursday, January 14, 2016, in the Elizabethan D room at the Westin St. Francis Hotel in San Francisco.
